BRPI0924296A2 - composição farmacêutica para tratar do câncer compreendendo um composto conjugado de cloro e6-ácido fólico e quitosana - Google Patents
composição farmacêutica para tratar do câncer compreendendo um composto conjugado de cloro e6-ácido fólico e quitosanaInfo
- Publication number
- BRPI0924296A2 BRPI0924296A2 BRPI0924296A BRPI0924296A BRPI0924296A2 BR PI0924296 A2 BRPI0924296 A2 BR PI0924296A2 BR PI0924296 A BRPI0924296 A BR PI0924296A BR PI0924296 A BRPI0924296 A BR PI0924296A BR PI0924296 A2 BRPI0924296 A2 BR PI0924296A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- treating cancer
- folic acid
- chitosan compound
- conjugated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2009/002277 WO2010126179A1 (ko) | 2009-04-29 | 2009-04-29 | 클로린 e6-엽산 결합 화합물 및 키토산을 함유하는 암 치료용 약학적 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0924296A2 true BRPI0924296A2 (pt) | 2019-09-24 |
Family
ID=43032311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0924296A BRPI0924296A2 (pt) | 2009-04-29 | 2009-04-29 | composição farmacêutica para tratar do câncer compreendendo um composto conjugado de cloro e6-ácido fólico e quitosana |
Country Status (6)
Country | Link |
---|---|
US (1) | US20120035180A1 (pt) |
EP (1) | EP2431040A1 (pt) |
JP (1) | JP2011518891A (pt) |
CN (1) | CN101977608A (pt) |
BR (1) | BRPI0924296A2 (pt) |
WO (1) | WO2010126179A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201208548D0 (en) | 2012-05-15 | 2012-06-27 | Pci Biotech As | Compound and method |
CN106279212B (zh) * | 2016-08-01 | 2019-06-18 | 康宏耀源(天津)科技有限公司 | 以叶酸为靶向基团的光敏药物的合成和应用 |
KR102173861B1 (ko) | 2019-02-12 | 2020-11-05 | 한국화학연구원 | 약물담지용 키토산 나노섬유 복합체 및 이의 제조방법 |
RU2704202C1 (ru) * | 2019-07-03 | 2019-10-24 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ фотодинамической терапии перевивной поверхностной солидной соединительнотканной саркомы м-1 крыс |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688721T2 (de) * | 1985-04-30 | 1993-12-16 | Nippon Petrochemicals Co Ltd | Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren. |
EP1150655B1 (de) * | 1999-02-09 | 2003-09-17 | Cognis Deutschland GmbH & Co. KG | Verwendung von nanoskaligen chitosanen |
GB0520436D0 (en) * | 2005-10-07 | 2005-11-16 | Photobiotics Ltd | Biological materials and uses thereof |
-
2009
- 2009-04-29 CN CN2009800002080A patent/CN101977608A/zh active Pending
- 2009-04-29 WO PCT/KR2009/002277 patent/WO2010126179A1/ko active Application Filing
- 2009-04-29 JP JP2011511497A patent/JP2011518891A/ja active Pending
- 2009-04-29 US US12/594,180 patent/US20120035180A1/en not_active Abandoned
- 2009-04-29 BR BRPI0924296A patent/BRPI0924296A2/pt not_active IP Right Cessation
- 2009-04-29 EP EP09844061A patent/EP2431040A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN101977608A (zh) | 2011-02-16 |
WO2010126179A1 (ko) | 2010-11-04 |
EP2431040A1 (en) | 2012-03-21 |
US20120035180A1 (en) | 2012-02-09 |
JP2011518891A (ja) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL255097A0 (en) | Antimicrobial compounds, pharmaceutical preparations containing them and their uses | |
BR112012018947A2 (pt) | composição farmacêutica para tratamento e\ou prevenção do cancêr | |
SMT201600259B (it) | Composizioni farmaceutiche antibatteriche | |
IL215079A (en) | A pharmacological preparation containing colchicine or thiocholchicine for the treatment of a thriving disease | |
PL2532366T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
EP2532364A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF CANCER | |
BRPI0905717A2 (pt) | Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica | |
AR066564A1 (es) | Una combinacion farmaceutica sinergica para el tratamiento de cancer | |
BRPI1008566A8 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
BRPI1008564A2 (pt) | métodos e composições para o dignóstico e tratamento de câncer | |
BRPI0908635A2 (pt) | composto, composição farmacêutica e método de tratamento de câncer | |
BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
BR112012004080A2 (pt) | composições farmacêuticas para tratar ibd | |
BR112013011967A2 (pt) | composição biodegradável para distribuição de fármaco | |
BRPI1010874A8 (pt) | composição para o tratamento de câncer de próstata | |
BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
EP2445485A4 (en) | DRUG MEDICINE | |
BRPI0922367A2 (pt) | enzastaurin para o tratamento de câncer | |
BRPI0918508A2 (pt) | orto-aminoanilidas para o tratamento de câncer | |
BRPI0924296A2 (pt) | composição farmacêutica para tratar do câncer compreendendo um composto conjugado de cloro e6-ácido fólico e quitosana | |
EP2689777A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING HEPATIC DISEASES | |
BR112012004701A2 (pt) | compostos e composições para tratamento do câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |